Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-31 @ 7:09 AM
Study NCT ID:
NCT07359066
Status:
RECRUITING
Last Update Posted:
2026-02-05
First Post:
2025-12-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label, First-in-Human, Dose-Escalation and Dose-Expansion Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPR1020 in Patients With Advanced Solid Tumors
Sponsor:
Shanghai SciBrunch Therapeutics Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-01-08
Start Date Type:
ACTUAL
Primary Completion Date:
2028-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-12-16
First Submit QC Date:
None
Study First Post Date:
2026-01-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-02-03
Last Update Post Date:
2026-02-05
Last Update Post Date Type:
ACTUAL